ZURICH/GDANSK, July 23 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday:
ROCHE HOLDING ROG.S
Roche said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside the U.S., effective Tuesday.
LONZA GROUP LONN.S
The Swiss contract drug manufacturer reported a rise in its half-year core earnings on Wednesday, beating market expectations, aided by contributions from its Vacaville site in the U.S and strong performance in the mammalian, bioconjugates and small molecules technology platforms.
COMPANY STATEMENTS
*VAT GROUP VACN.S says Q2 Sales at CHF 282.9 Million
*TEMENOS TEMN.S raises FY guidance
ANALYSTS' VIEWS
*GIVAUDANGIVN.S - JP Morgan cuts target price to CHF 4,200 from CHF 4,300
ECONOMY
SNB US Dollar auction due at 0900 GMT.
(Reporting by Zurich newsroom and Gdansk newsroom)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS